zandelisib
Zandelisib is a drug used to treat CLL, Follicular Lymphoma (FL), Marginal Zone Lymphoma, and other conditions. Zandelisib is being actively studied in 2 studies; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| MEI Pharma, Inc. | AZ Sint-Jan Burgge-Oostende AV | |
| Alpha Research Institute, LLC | ||
| Anjo Kosei Hospital |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Not yet recruiting
- CLL
- Zandelisib
- +2 more
- (no location specified)
2022-02-08
Feb 8, 2022M
Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)
Recruiting
- Follicular Lymphoma (FL)
- +2 more
- Zandelisib
- +3 more
- Tucson, Arizona
- +97 more
2022-03-10
Mar 10, 2022